Allstate Corporation’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Allstate Corporation's EXEL Position: Q2 2026 in Review
Allstate Corporation reduced its Exelixis (EXEL) stake by 44% in Q2 2026, selling an estimated $664K and leaving 17,193 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #777.
Allstate Corporation first reported a position in EXEL in Q2 2019 and has held it in 3 quarters since. The position peaked at $1.32M in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Allstate Corporation held 17,193 shares of Exelixis worth $935K as of Q2 2026.
- Allstate Corporation sold 13,634 Exelixis shares in Q2 2026, an estimated $664K.
- Exelixis made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #777 holding.
- Allstate Corporation first reported a position in Exelixis in Q2 2019 and has held it in 3 quarters since.
- Allstate Corporation's Exelixis position peaked at $1.32M in Q1 2026.
- 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.